Skip to main content

Table 1 Correlation between SLC39A1 and 22 subtypes of immune cell in glioma samples

From: SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas

Inmune cells Cor P
Macrophages M2 0.336 < 0.001
Macrophages M0 0.309 < 0.001
Eosinophils 0.261 < 0.001
T cells regulatory (Tregs) 0.195 < 0.001
T cells gamma delta 0.18 < 0.001
Macrophages M1 0.093 0.013
T cells CD4 memory activated 0.081 0.032
Dendritic cells activated 0.067 0.076
NK cells resting 0.053 0.16
T cells CD4 memory resting 0.051 0.18
Neutrophils 0.022 0.564
T cells CD8 −0.033 0.384
Plasma cells −0.039 0.305
Dendritic cells resting −0.049 0.192
B cells naive −0.094 0.012
B cells memory −0.101 0.007
Mast cells resting −0.18 < 0.001
T cells follicular helper −0.181 < 0.001
Monocytes −0.193 < 0.001
Mast cells activated −0.211 < 0.001
T cells CD4 naive −0.24 < 0.001
NK cells activated −0.268 < 0.001